Antibacterial and anti‐inflammatory activity of a temporin B peptide analogue on an in vitro model of cystic fibrosis
暂无分享,去创建一个
R. Gambari | M. Borgatti | I. Lampronti | V. Bezzerri | G. Cabrini | C. Avitabile | A. Romanelli | M. Dechecchi | G. Montagner
[1] C. Avitabile,et al. Circular Dichroism studies on the interactions of antimicrobial peptides with bacterial cells , 2014, Scientific Reports.
[2] R. Fattorusso,et al. Design, structural and functional characterization of a Temporin-1b analog active against Gram-negative bacteria. , 2013, Biochimica et biophysica acta.
[3] A. Pini,et al. Esculentin(1-21), an amphibian skin membrane-active peptide with potent activity on both planktonic and biofilm cells of the bacterial pathogen Pseudomonas aeruginosa , 2013, Cellular and Molecular Life Sciences.
[4] A. Schmidtchen,et al. Host Defense Peptides of Thrombin Modulate Inflammation and Coagulation in Endotoxin-Mediated Shock and Pseudomonas aeruginosa Sepsis , 2012, PloS one.
[5] C. Kan,et al. Corilagin is a potent inhibitor of NF-kappaB activity and downregulates TNF-alpha induced expression of IL-8 gene in cystic fibrosis IB3-1 cells. , 2012, International immunopharmacology.
[6] R. Hoffmann,et al. Api88 is a novel antibacterial designer peptide to treat systemic infections with multidrug-resistant Gram-negative pathogens. , 2012, ACS chemical biology.
[7] S. Bhattacharjya,et al. NMR Structures and Interactions of Temporin-1Tl and Temporin-1Tb with Lipopolysaccharide Micelles , 2011, The Journal of Biological Chemistry.
[8] P. Campiglia,et al. Peptides from Royal Jelly: studies on the antimicrobial activity of jelleins, jelleins analogs and synergy with temporins , 2011, Journal of peptide science : an official publication of the European Peptide Society.
[9] R. Gambari,et al. Trimethylangelicin reduces IL-8 transcription and potentiates CFTR function. , 2011, American journal of physiology. Lung cellular and molecular physiology.
[10] R. Gambari,et al. Decoy oligodeoxyribonucleotides and peptide nucleic acids-DNA chimeras targeting nuclear factor kappa-B: inhibition of IL-8 gene expression in cystic fibrosis cells infected with Pseudomonas aeruginosa. , 2010, Biochemical pharmacology.
[11] D. Barra,et al. Anti-Pseudomonas Activity of Frog Skin Antimicrobial Peptides in a Caenorhabditis elegans Infection Model: a Plausible Mode of Action In Vitro and In Vivo , 2010, Antimicrobial Agents and Chemotherapy.
[12] R. Gambari,et al. Modulation of expression of IL-8 gene in bronchial epithelial cells by 5-methoxypsoralen. , 2009, International immunopharmacology.
[13] C. Pedone,et al. Synergistic Antibacterial and Anti-Inflammatory Activity of Temporin A and Modified Temporin B In Vivo , 2009, PloS one.
[14] Y. Shai,et al. Parameters involved in antimicrobial and endotoxin detoxification activities of antimicrobial peptides. , 2008, Biochemistry.
[15] R. Gambari,et al. Transcription factor oligodeoxynucleotides to NF-kappaB inhibit transcription of IL-8 in bronchial cells. , 2008, American journal of respiratory cell and molecular biology.
[16] R. Gambari,et al. Evaluation of chemokine and cytokine profiles in osteoblast progenitors from umbilical cord blood stem cells by BIO‐PLEX technology , 2008, Cell biology international.
[17] G. Pier. Pseudomonas aeruginosa lipopolysaccharide: a major virulence factor, initiator of inflammation and target for effective immunity. , 2007, International journal of medical microbiology : IJMM.
[18] A. Chattopadhyay,et al. Orientation and dynamics of melittin in membranes of varying composition utilizing NBD fluorescence. , 2007, Biophysical journal.
[19] P. F. Nielsen,et al. A family of brevinin-2 peptides with potent activity against Pseudomonas aeruginosa from the skin of the Hokkaido frog, Rana pirica , 2004, Regulatory Peptides.
[20] S. Randell,et al. Cytokine secretion by cystic fibrosis airway epithelial cells. , 2004, American journal of respiratory and critical care medicine.
[21] W. Kuis,et al. Simultaneous Detection of 15 Human Cytokines in a Single Sample of Stimulated Peripheral Blood Mononuclear Cells , 2003, Clinical Diagnostic Laboratory Immunology.
[22] P. Kinnunen,et al. Temporin L: antimicrobial, haemolytic and cytotoxic activities, and effects on membrane permeabilization in lipid vesicles. , 2002, The Biochemical journal.
[23] D. Wade,et al. Temporin antibiotic peptides: A review and derivation of a consensus sequence , 2000, Protein & Peptide Letters.
[24] R. Hancock,et al. Antibiotic resistance in Pseudomonas aeruginosa: mechanisms and impact on treatment. , 2000, Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy.
[25] F. Barchiesi,et al. In-vitro activity of cationic peptides alone and in combination with clinically used antimicrobial agents against Pseudomonas aeruginosa. , 1999, The Journal of antimicrobial chemotherapy.
[26] T. Noah,et al. Interleukin-8 production by cystic fibrosis nasal epithelial cells after tumor necrosis factor-alpha and respiratory syncytial virus stimulation. , 1998, American journal of respiratory cell and molecular biology.
[27] D. Barra,et al. Temporins, antimicrobial peptides from the European red frog Rana temporaria. , 1996, European journal of biochemistry.
[28] M. Konstan,et al. Inflammatory cytokines in cystic fibrosis lungs. , 1995, American journal of respiratory and critical care medicine.
[29] F. Bossa,et al. Antimicrobial peptides from skin secretions of Rana esculenta. Molecular cloning of cDNAs encoding esculentin and brevinins and isolation of new active peptides. , 1994, The Journal of biological chemistry.
[30] M. Hodson,et al. AEROSOL CARBENICILLIN AND GENTAMICIN TREATMENT OF PSEUDOMONAS AERUGINOSA INFECTION IN PATIENTS WITH CYSTIC FIBROSIS , 1981, The Lancet.